Globus Medical Stock Analysis (NYSE:GMED)

Add to My Stocks
$29.88 $0.08 (0.27%) GMED stock closing price Mar 27, 2017 (Closing)
Watch Robo Advisor Video of GMED Stock Analysis
Globus Medical
Updated on : Mar 27, 2017
previous close
GMED 29.9 (0%)
S&P 500 2341.6 (0%)
Closing Price On: Mar 27, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Instruments
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q4
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
27.2%
Sector Average:
-6.4%
5 Quarter Net Profit
Net Margins
2016-Q4
%
LTM Margin
Compared to the industry
Cash Flow
Operating cash flow:
$51.9M
Net Income:
$24.3M
PROS      CONS
Operating Margins
Net Margins
Cash Flow
ROIC
ROE
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
GMED PS :
5.1
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
20.7%
Return on Equity:
13.4%
Free Cash Flow Margin:
24.9%
Double Tap To Exit Full Screen
0:00
/

Globus Medical Analysis Video

88 5 2

View Globus Medical stock analysis video. This is our GMED analyst opinion covering the buy and sell arguments for GMED stock.

Globus Medical Inc Stock Rating (3.9/5)

Our Globus Medical stock opinion is based on fundamentals of the company. This Globus Medical stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy GMED stock?

  • The TTM operating margin was good at 27.2% for Globus Medical.
  • Net margins came in at average 18.5% for Globus Medical over the last twelve months.
  • The company has an operating cash flow which is 2.1 times the net income. We see this as a positive signal.
  • Globus Medical generates a high return on invested capital of 20.7%.
  • The LTM ROE of 13.4% for Globus Medical is attractive.
  • Globus Medical has a healthy FCF (Free Cash Flow) margin of 24.9%.

Should you sell GMED stock?

Comments on this video and Globus Medical stock